David A. Frank
Associate Professor
Hematologic OncologyÂ
Dana-Farber Cancer Institute
United States of America
Biography
Dr. Frank received his MD in 1986 and PhD in 1987 from Yale University. After serving as an intern, resident, and chief resident in internal medicine at Yale, he completed training in medical oncology at Dana-Farber Cancer Institute, followed by a postdoctoral fellowship in intracellular signal transduction at Harvard Medical School.
Research Interest
Leukemia
Publications
-
Hu T, Yeh JE, Pinello L, Jacob J, Chakravarthy S et al (2015) Impact of the N-Terminal Domain of STAT3 in STAT3-Dependent Transcriptional Activity. Mol Cell Biol 19 :3284-3300.
-
Yeh JE, Frank DA (2016) STAT3-Interacting Proteins as Modulators of Transcription Factor Function: Implications to Targeted Cancer Therapy. ChemMedChem 8 :795-801.
-
Xiang M, Kim H, Ho VT, Walker SR1, Bar-Natan M et al (2016) Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anti-cancer agent. Blood.
